v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 118,764 $ 88,205
Marketable securities 479,227 688,723
Accounts receivable, net 3,453 2,810
Inventory 23,070 19,076
Prepaid expenses and other current assets 39,113 35,021
Total current assets 663,627 833,835
Marketable securities 116,301 29,435
Operating lease assets 51,606 54,409
Property and equipment, net 14,119 15,382
Other non-current assets 4,056 4,057
Total assets 849,709 937,118
Current liabilities:    
Accounts payable 11,155 9,780
Accrued expenses 25,129 43,167
Operating lease liabilities 15,407 15,008
Total current liabilities 51,691 67,955
Operating lease liabilities, net of current portion 52,940 56,988
Other non-current liabilities 1,156 1,156
Total liabilities 105,787 126,099
Stockholders’ equity:    
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at March 31, 2024 and December 31, 2023 0 0
Common stock, $0.001 par value; 125,000,000 shares authorized; 72,967,922 shares issued and 56,751,511 shares outstanding at March 31, 2024, and 72,161,489 shares issued and 55,945,078 shares outstanding at December 31, 2023 73 72
Additional paid-in capital 2,451,620 2,436,523
Accumulated other comprehensive loss (1,087) (441)
Treasury stock, at cost (16,216,411 shares at March 31, 2024 and December 31, 2023) (802,486) (802,486)
Accumulated deficit (904,198) (822,649)
Total stockholders’ equity 743,922 811,019
Total liabilities and stockholders’ equity $ 849,709 $ 937,118